Invokana Class Action Lawsuit
Saturday September 13, 2025 — The U.S. Food and Drug Administration recently issued safety warnings about serious side effects associated with Invokana, including:
- Leg and foot amputations
- Diabetic ketoacidosis (DKA)
- Blood infection (urosepsis)
- Kidney infection (pyelonephritis)
- Renal failure
Lawsuits are now underway to compensate patients who were not properly warned about these dangers prior to taking the medication.
If you have questions about joining an Invokana class action lawsuit, contact our experienced drug injury lawyers for a free case review.
Invokana Class Action Not Formed
The FDA first approved Invokana for sale in the United States in 2013 and the drug has reached over 5 million prescriptions. Despite widespread use of Invokana, the litigation is not structured as a class action lawsuit.
In an Invokana class action, a single lawsuit would be filed on behalf of all victims with any proceeds divided among those who join the class.
For cases involving complicated medical injuries, however, the class action system may not accurately compensate each individual claimant.
Given the serious nature of kidney failure, amputations, and other Invokana side effects, our lawyers file a separate lawsuit on behalf of each client and litigate every Invokana case individually.
This means you will have your own lawyer to represent you and guide you step-by-step through your case. You will also be able to pursue compensation for the full range of your legal damages including medical expenses, lost wages, pain, suffering, and emotional distress.
Compared to a large class action, this approach gives our lawyers a better opportunity to bring your individual case to a fast and fair resolution.
Invokana Lawsuits Allege Failure To Warn Patients
Invokana is in a class of medications called sodium-glucose co-trasnporter 2 (SGLT2) inhibitors. These drugs cause glucose to pass through the kidneys and out of the body, thus lowering blood sugar levels.
In December 2015, the FDA announced that Invokana must include heightened safety warnings to consumers because the drug can dangerously elevate blood acid levels and cause serious urinary tract infections.
The FDA’s action came after similar warnings from the Canadian government and European health officials.
More recently, in May 2017 the FDA added a Boxed Warning, the agency’s strongest safety label, to warn patients about an increased risk of limb loss and amputations associated with Invokana.
Lawyers for the affected patients allege the drug’s manufacturer was aware of significant risks yet continued to promote the medication as safe and effective. Other legal claims include defective design, negligence, fraud, and breach of warranties.
Get a Free Invokana Case Review
The first step in your case is to receive an initial consultation from a knowledgeable drug injury lawyer.
Our firm has over 25 years’ experience in complex pharmaceutical litigation and we represent all Invokana clients on a no-fee, contingency basis.
Contact our lawyers by phone or online at any time to review your case and learn how we can help.